Posts in tag

weight loss medication


TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to …

Shortages of diabetes medication, Ozempic (semaglutide), fueled by off-label prescribing of it as a weight-loss treatment, highlight the need for new drugs to tackle obesity.   With supplier, Novo Nordisk …

A Sydney doctor whose prescribing of compounded stimulants to at-risk patients was described as ‘reprehensible’ has been struck off the register, while a compounding pharmacist will front the tribunal A …

Systematic review and meta-analysis involving 30,000 patients reveals success of weight loss agents The review published in JAMA looked at five medications approved for management of obesity in the US: orlistat, …